Parameter
| Biomarker | Neutrophil percentage-albumin ratio (NPAR) | Full name | Neutrophil percentage-albumin ratio | Molecular Type | A composite measure of inflammation/nutrition |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Inflammation and hepatic synthetic function | ||
| Disease | Metabolic Associated Fatty Liver Disease (MASLD) | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | Serum (blood routine, biochemical tests) | ||
| Pathobiological Mechanisms | Increased neutrophils (inflammation) and decreased albumin (impaired liver synthesis), SMD=0.28, AUC=76.05% | ||||
| Clinical Availability Status | It is clinically available and easy to be carried out in primary hospitals | ||||
| Notes and Dynamics | It is low cost, easy to operate, and suitable for large-scale screening | ||||